Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Pancreatic Neoplasms 3Lung Neoplasms 2Carcinoma, Renal Cell 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Lung Diseases 1Kidney Neoplasms 1Esophageal Neoplasms 1Erythrocytosis, Familial, 4 1Cholangiocarcinoma 1Advanced Non-Small Cell Lung Cancer 1

Interventions

Oxaliplatin 7Fluorouracil 7Paclitaxel 5Leucovorin 5pembrolizumab 4Trastuzumab 4Radiation 4Capecitabine 4tislelizumab 3Taxes 3Specimen Handling 3Nivolumab 3Carboplatin 3ulixertinib 2trastuzumab biosimilar HLX02 2patritumab deruxtecan 2Surgical Procedures, Operative 2Radiotherapy 2Pemetrexed 2PF-05280014 2Ontruzant 2Ogivri 2Irinotecan 2Exercise 2Docetaxel 2Cisplatin 2CT-P6 2zolbetuximab 1zimberelimab 1zanidatamab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × zimberelimab × 30 days × Clear all
NCT05891171 2026-06-05

ARC-25

Arcus Biosciences, Inc.

Phase 1 Active not recruiting
40 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡